Sign up to our newsletter
and receive exclusive information and discount coupons straight to your inbox

News tag: dinutuximab


pediatric_polysomnogram_cancer

New drug gets FDA’s approval for battling pediatric cancer


12 Mar, 2015 | by Ion Gireada | 0 comments
The Food and Drug Administration said it approved United Therapeutics Corp's drug to treat neuroblastoma, a rare cancer that typically occurs in children below 5 years. Unituxin is the first drug approved to treat high-risk neuroblastoma patients who have a greater chance of tumors recurring or progressing after chemotherapy. Patients…